What We Do

The Elephas Live™ platform is designed to be placed within pathology labs to predict response to immunotherapy. Unlike tests which require specimens to be sent to a central lab, the Elephas Live™ platform allows providers to keep specimens on site and run a test within 72 hours. The platform will enable providers to test tumor biopsies against any available therapy or combination.

We will generate unprecedented, large datasets from live core needle biopsies. As clinical results are generated, all data to date is deidentified and shown as a population level reference to providers interpreting results. In the future, AI algorithms applied to interpret large, orthogonal datasets will drive increased efficacy of the platform and better patient outcomes.

Researchers can use the platform to phenotypically profile live tissue. The Elephas Live™ platform will redefine phenotypic testing by allowing for live tissue assessments over time.